United States v. McMahon — Fifth Circuit affirms sentencing enhancement for drug premises

Case
United States v. McMahon
Court
U.S. Court of Appeals for the Fifth Circuit
Judge
Haynes (George W. Bush, 2008); Graves (Barack Obama, 2011); Ramirez (Joe Biden, 2023)
Date Decided
2026-07-27
Docket No.
25-40548
Topics
Sentencing Enhancement; Drug Offenses; Plain Error Review; U.S.S.G.
Source
Read the full opinion

Background

Leotis Cornelius McMahon was convicted of possession with intent to distribute 50 grams or more of methamphetamine and possession of a firearm by a felon. He received a total sentence of 400 months of imprisonment, which fell within the applicable guidelines range.

McMahon appealed his conviction, specifically challenging the application of a two-level enhancement to his sentence. This enhancement, codified under U.S.S.G. § 2D1.1(b)(12) and its accompanying commentary (n.17), is for maintaining a premises for the purpose of manufacturing or distributing a controlled substance. McMahon argued that the evidence presented did not sufficiently establish that drug activity was a primary or principal use of the premises in question.

The Court’s Holding

The Fifth Circuit Court of Appeals affirmed the district court’s application of the two-level sentencing enhancement. The court first clarified that McMahon’s counsel did not waive the specific issue on appeal, but because McMahon did not clearly raise this particular objection in the district court, the appellate court reviewed the issue for plain error.

The court concluded that the district court did not commit an error that was “clear or obvious” in finding the enhancement applicable. Referencing precedent, the Fifth Circuit noted that district courts are permitted to draw reasonable inferences from the facts, and that there is a “low bar” for establishing that drug manufacturing or distribution was a primary use of the premises. In McMahon’s case, the court found that the undisputed evidence detailed in the presentence report supported a reasonable inference that his residence was indeed primarily used for storing, manufacturing, and preparing controlled substances for distribution.

Key Takeaways

  • Appellate review of sentencing enhancements is subject to plain error standard if the issue was not clearly raised in the district court.
  • The Fifth Circuit maintains a “low bar” for establishing that a premises’ primary use was for drug manufacturing or distribution under U.S.S.G. § 2D1.1(b)(12).
  • District courts can reasonably infer primary use for drug activity from evidence, including details in a presentence report.

Why It Matters

This ruling reinforces the challenging standard of plain error review for sentencing issues not adequately preserved in the trial court. Defense attorneys must ensure all objections to sentencing enhancements, particularly those under the U.S. Sentencing Guidelines, are clearly and specifically articulated during district court proceedings to avoid a significantly higher burden on appeal.

Furthermore, the decision underscores the Fifth Circuit’s expansive interpretation of “primary use” for drug premises enhancements. It signals that appellate courts will defer to reasonable inferences drawn by district courts regarding the purpose of a premises, even with a “low bar” of evidence, as long as there is supporting factual information like that found in presentence reports.

✉️ Get tomorrow’s cases before your first coffee
Daily Case Law is our free morning digest — the most substantive new decisions, filtered to your jurisdictions and topics, each linking back here for the full analysis.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top